Report cover image

Global Fibroadenoma Market Size Study, by Type (Simple Fibroadenoma, Complex Fibroadenoma), by Diagnosis & Treatment (Diagnosis, Treatment), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others) and Regional Forecasts 2024-2032

Publisher Bizwit Research & Consulting
Published Aug 20, 2024
Length 285 Pages
SKU # BIZW19091599

Description

Global Fibroadenoma Market Size Study, by Type (Simple Fibroadenoma, Complex Fibroadenoma), by Diagnosis & Treatment (Diagnosis, Treatment), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others) and Regional Forecasts 2024-2032


The Global Fibroadenoma Market was valued at approximately USD 715.06 Million in 2023 and is anticipated to grow with a healthy growth rate of more than 6.58% over the forecast period 2024-2032. Fibroadenoma is a common type of benign (non-cancerous) breast tumor that typically occurs in young women. It is characterized by a mixture of stromal (connective) and glandular (milk-producing) tissue. Fibroadenomas are usually round, firm, and smooth with well-defined borders and can be easily moved within the breast tissue when touched. Public education campaigns play a pivotal role in informing women about the signs and symptoms of fibroadenoma, encouraging proactive health-seeking behavior and prompting regular breast examinations and screenings. The development of improved diagnostic techniques further enhances the precision of detection, contributing to market growth.

Increased awareness about fibroadenoma through public education campaigns has significantly driven demand in the fibroadenoma market. These campaigns have enhanced knowledge about the condition, emphasizing the importance of early detection and regular breast self-examinations. As a result, more women are seeking medical consultations and screenings, leading to a rise in the diagnosis and management of fibroadenomas. Educational initiatives by healthcare organizations, government agencies, and advocacy groups have also played a crucial role in destigmatizing breast health issues, encouraging open discussions, and reducing fear associated with benign breast tumors. Additionally, these campaigns have highlighted advancements in minimally invasive diagnostic and treatment options, making them more accessible and appealing. Consequently, the heightened awareness and proactive approach towards fibroadenoma have expanded the market, driving demand for diagnostic tools, therapeutic procedures, and follow-up care services.

Key regions considered for the global Fibroadenoma market study include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest market share in 2023 due to advanced diagnostic techniques, medical infrastructure, and favorable reimbursement policies. The region's market growth was further supported by the presence of leading medical device manufacturers and biotechnology companies, which fostered innovation in diagnostic and treatment solutions. High healthcare expenditure and favorable reimbursement policies also contributed to the market's expansion. Additionally, the rising incidence of fibroadenoma cases and the growing adoption of minimally invasive procedures for their management reinforced North America's leadership in the global fibroadenoma market. Europe is projected to show significant growth during the forecast period, driven by the increasing focus on minimally invasive procedures. The Asia-Pacific region is expected to be the fastest-growing market due to frequent launches of breast diagnosis and treatment machines.

Major market players included in this report are:

GE Healthcare

Koninklijke Philips N.V.

Shimadzu Corporation

Siemens Healthineers

Canon Medical Systems Corporation

Dilon Technologies

Pfizer, Inc.

IceCure Medical

Alpinion Medical Systems

Fujifilm Holdings Corporation.

The detailed segments and sub-segments of the market are explained below:

By Type:

Simple Fibroadenoma

Complex Fibroadenoma

By Diagnosis & Treatment:

Diagnosis
• Ultrasound Scan
• Mammography
• Biopsy

Treatment
• Cryoblation
• High-Intensity Focused Ultrasound (HIFU)
• Lumpectomy
• Drugs

By End User:

Hospitals & Clinics

Ambulatory Surgical Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia-Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of Latin America

Middle East & Africa

Saudi Arabia

South Africa

RoMEA

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.

Annualized revenues and regional level analysis for each market segment.

Detailed analysis of geographical landscape with Country level analysis of major regions.

Competitive landscape with information on major players in the market.

Analysis of key business strategies and recommendations on future market approach.

Analysis of competitive structure of the market.

Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Fibroadenoma Market Executive Summary
1.1. Global Fibroadenoma Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Diagnosis & Treatment
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Fibroadenoma Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Fibroadenoma Market Dynamics
3.1. Market Drivers
3.1.1. Increased awareness about fibroadenoma through public education campaigns
3.1.2 Rising incidence of fibroadenoma cases
3.1.3. Advancements in diagnostic techniques
3.2. Market Challenges
3.2.1. High equipment costs
3.3. Market Opportunities
3.3.1. Technological advancements for early diagnosis
3.3.2. Growing adoption of minimally invasive procedures
Chapter 4. Global Fibroadenoma Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Fibroadenoma Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Fibroadenoma Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Simple Fibroadenoma
5.2.2. Complex Fibroadenoma
Chapter 6. Global Fibroadenoma Market Size & Forecasts by Diagnosis & Treatment 2022-2032
6.1. Segment Dashboard
6.2. Global Fibroadenoma Market: Diagnosis & Treatment Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Diagnosis
Ultrasound Scan
Mammography
Biopsy
6.2.2. Treatment
Cryoblation
High-Intensity Focused Ultrasound (HIFU)
Lumpectomy
Drugs
Chapter 7. Global Fibroadenoma Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Fibroadenoma Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Hospitals & Clinics
7.2.2. Ambulatory Surgical Centers
7.2.3. Others
Chapter 8. Global Fibroadenoma Market Size & Forecasts by Region 2022-2032
8.1. North America Fibroadenoma Market
8.1.1. U.S. Fibroadenoma Market
8.1.1.1. Type breakdown size & forecasts, 2022-2032
8.1.1.2. Diagnosis & Treatment breakdown size & forecasts, 2022-2032
8.1.1.3. End User breakdown size & forecasts, 2022-2032
8.1.2. Canada Fibroadenoma Market
8.2. Europe Fibroadenoma Market
8.2.1. U.K. Fibroadenoma Market
8.2.2. Germany Fibroadenoma Market
8.2.3. France Fibroadenoma Market
8.2.4. Spain Fibroadenoma Market
8.2.5. Italy Fibroadenoma Market
8.2.6. Rest of Europe Fibroadenoma Market
8.3. Asia-Pacific Fibroadenoma Market
8.3.1. China Fibroadenoma Market
8.3.2. India Fibroadenoma Market
8.3.3. Japan Fibroadenoma Market
8.3.4. Australia Fibroadenoma Market
8.3.5. South Korea Fibroadenoma Market
8.3.6. Rest of Asia Pacific Fibroadenoma Market
8.4. Latin America Fibroadenoma Market
8.4.1. Brazil Fibroadenoma Market
8.4.2. Mexico Fibroadenoma Market
8.4.3. Rest of Latin America Fibroadenoma Market
8.5. Middle East & Africa Fibroadenoma Market
8.5.1. Saudi Arabia Fibroadenoma Market
8.5.2. South Africa Fibroadenoma Market
8.5.3. Rest of Middle East & Africa Fibroadenoma Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GE Healthcare
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Koninklijke Philips N.V.
9.3.3. Shimadzu Corporation
9.3.4. Siemens Healthineers
9.3.5. Canon Medical Systems Corporation
9.3.6. Dilon Technologies
9.3.7. Pfizer, Inc.
9.3.8. IceCure Medical
9.3.9. Alpinion Medical Systems
9.3.10. Fujifilm Holdings Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Fibroadenoma market, report scope
TABLE 2. Global Fibroadenoma market estimates & forecasts by Region 2022-2032 (USD Million)
TABLE 3. Global Fibroadenoma market estimates & forecasts by Type 2022-2032 (USD Million)
TABLE 4. Global Fibroadenoma market estimates & forecasts by Diagnosis & Treatment 2022-2032 (USD Million)
TABLE 5. Global Fibroadenoma market estimates & forecasts by End User 2022-2032 (USD Million)
TABLE 6. U.S. Fibroadenoma market estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Canada Fibroadenoma market estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. U.K. Fibroadenoma market estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Germany Fibroadenoma market estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. France Fibroadenoma market estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. China Fibroadenoma market estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. India Fibroadenoma market estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Japan Fibroadenoma market estimates & forecasts, 2022-2032 (USD Million)
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIGURE 1. Global Fibroadenoma market, research methodology
FIGURE 2. Global Fibroadenoma market, market estimation techniques
FIGURE 3. Global market size estimates & forecast methods.
FIGURE 4. Global Fibroadenoma market, key trends 2023
FIGURE 5. Global Fibroadenoma market, growth prospects 2022-2032
FIGURE 6. Global Fibroadenoma market, porters 5 force model
FIGURE 7. Global Fibroadenoma market, PESTEL analysis
FIGURE 8. Global Fibroadenoma market, value chain analysis
FIGURE 9. Global Fibroadenoma market by Type, 2022 & 2032 (USD Million)
FIGURE 10. Global Fibroadenoma market by Diagnosis & Treatment, 2022 & 2032 (USD Million)
FIGURE 11. U.S. Fibroadenoma market estimates, 2022 & 2032 (USD Million)
FIGURE 12. Europe Fibroadenoma market estimates, 2022 & 2032 (USD Million)
FIGURE 13. Asia-Pacific Fibroadenoma market estimates, 2022 & 2032 (USD Million)
FIGURE 14. Latin America Fibroadenoma market estimates, 2022 & 2032 (USD Million)
FIGURE 15. Middle East & Africa Fibroadenoma market estimates, 2022 & 2032 (USD Million)
FIGURE 16. Global Fibroadenoma market, company market share analysis (2023)
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us